MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) today announced it will host a live webcast to provide a summary of the Company’s data, including its flagship product Tarceva® (erlotinib), presented during the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, FL. The webcast will be hosted by Colin Goddard, Ph.D., Chief Executive Officer of OSI Pharmaceuticals and OSI's Oncology Management Team. The webcast will begin at 7:30AM Eastern Time on Tuesday, June 2, 2009.
